|Home||» Products||» Anticancer Medicine||» Gemcitabine for Injection USP 200 mg|
Gemcitabine for Injection USP 200 mg
Our team of experienced professionals help us to manufacture and export a quality range of Gemcitabine Injection. For cell lung cancer and breast cancer treatment these drugs are highly used in medical institutions and hospitals. To formulate the drugs, we use best quality of compounds, sourced from the most authentic vendors. The Gemcitabine for Injection USP 200 mg is packed in air proof packaging materials and offered to the clients at the reasonable prices.
- Instant relief
- Non toxic
- Precise Composition
Gemcitabine Injection USP 200 mg (Lyophilized)
- Pancreatic Cancer
- Non-Small Cell Lung Cancer
- Breast Cancer
- Ovarian Cancer
Single-Agent Use : Pancreatic Cancer -Gemcitabine should be administered by intravenous infusion at a dose of 1000 mg/m2 over 30 minutes once weekly for up to 7 weeks (or until toxicity necessitates reducing or holding a dose), followed by a week of rest from treatment.
Subsequent cycles should consist of infusions once weekly for 3 consecutive weeks out of every 4 weeks.
Combination Use Non-Small Cell Lung Cancer : Two schedules have been investigated and the optimum schedule has not been determined. With the 4-week schedule, Gemcitabine should be administered intravenously at 1000 mg/m2 over 30 minutes on days 1, 8 and 15 of each 28-day cycle.
Cisplatin should be administered intravenously at 100 mg/m2 on day 1 after the infusion of Gemcitabine.
With the 3-week schedule, Gemcitabine should be administered intravenously at 1250 mg/m2 over 30 minutes on days 1 and 8 of each 21-day cycle.
Cisplatin at a dose of 100 mg/m2 should be administered intravenously after the infusion of Gemcitabine on day 1.
Breast Cancer : Gemcitabine should be administered intravenously at a dose of 1250 mg/m2 over 30 minutes on days 1 and 8 of each 21-day cycle. Paclitaxel should be administered at 175 mg/m2 on day 1 as a 3-hour intravenous infusion before Gemcitabine administration.
Ovarian Cancer : Gemcitabine should be administered intravenously at a dose of 1000 mg/m2 over 30 minutes on days 1 and 8 of each 21-day cycle. Carboplatin AUC 4 should be administered intravenously on day 1 after Gemcitabine administration.
Dosage Adjustment :
Renal Impairment : Administer with caution.
Hepatic Impairment : Administer with caution.
Packing : 5 Vials of 200 mg
We are also deal in:
|Name of the Product||Composition|
|Biogem 1000mg Injection||Gemcitabine 1000mg|
|Biogem 200mg Injection||Gemcitabine 200mg|